Introduction
============

In ICU patients, the mortality of enterococcal sepsis is high, and treatment is often difficult due to multiple antibiotic resistance. Aggregation substance (AS) is a surface protein of *E. faecalis*, which mediates transfer of (resistance) plasmids and was also identified as a virulence factor. We investigated whether AS may serve as target for antibodies in phagocytosis assays and in a murine sepsis model.

Methods
=======

Using the Qiagen pQE vector system, AS was expressed in *E. coli* and a histidine-tag served for purification by Ni-NTA chromatography. After purity was verified by western blot, AS was used to immunize rabbits. In phagocytosis assays, the immune rabbit sera (IRS) were compared with pre-immune sera for their opsonic activity, using human leukocytes, complement, and mutants of *E. faecalis* OG1. In order to show the specificity of the antibodies, the sera were absorbed with mutants of *E. faecalis* OG1 constitutively expressing (AS+), or not expressing AS (AS-). In the sepsis model, aliquots of IRS or normal rabbit sera (NRS) were used for IV passive immunization of Balb/c mice 24 hours before bacterial challenge, and 4 hours and 24 hours thereafter. IV bacterial challenge was performed via tail vein injection of AS+ *E. faecalis*. The mice were sacrificed 5 days thereafter for examination of bacterial levels in internal organs.

Results
=======

When incubated with IRS, the number of AS+ *E. faecalis* recovered at the end of the phagocytosis assay was reduced by more than 50% compared with incubation with pre-immune sera (*P* \< 0.01), whereas there was no difference against AS- strains. IRS was still opsonic after absorption with AS- *E. faecalis* but the activity was lost after absorption with AS+ mutants. In the mouse sepsis model, weight loss was significantly less in the IRS group (mean ± SD, 97.9 ± 3.6% of baseline weight) versus the NRS group (95.3 ± 2.9%, *P* = 0.04). The highest organ load with enterococci were found in the kidneys and the log cfu/g were significantly lower in the IRS group (*P* = 0.03).

Conclusion
==========

In our mouse sepsis model, antisera against AS significantly reduced weight loss and also the number of enterococci recovered from kidneys. The usefulness of AS as a target for antibodies is further confirmed by enhanced killing of AS+ enterococci by IRS. Our results are encouraging and point to the possibility of adjunctive immunotherapeutic approaches in enterococcal sepsis.
